首页 > 市场调查报告书 > 医疗设备

医学影像诊断

市场调查报告书

商品编码

1724760

数位病理学：技术与全球市场

Digital Pathology: Technologies and Global Markets

出版日期: 2025年04月29日 | 出版商:

BCC Research | 英文 170 Pages | 订单完成后即时交付

价格

简介目录图表

全球数位病理学市场规模预计将从 2024 年的 78 亿美元成长到 2029 年底的 137 亿美元，在 2024-2029 年预测期内的复合年增长率为 11.9%。

预计北美市场将从 2024 年的 33 亿美元扩大到 2029 年的 60 亿美元，同期的复合年增长率为 12.4%。预计欧洲市场将从 2024 年的 22 亿美元成长到 2029 年的 35 亿美元，预测期内的复合年增长率为 10.2%。

本报告调查了全球数位病理学市场，并提供了全面的市场概述、市场影响因素和市场机会的分析、法律制度、新兴技术和技术发展的趋势、市场规模的趋势和预测、各个细分市场和地区的详细分析、竞争格局以及主要企业的概况。

概述
驱动程式
成本效益推动数位病理学的扩展
扩大数位病理学的应用以提高实验室效率
癌症发生率增加
增加对数位病理学的投资和资金
限制因素
工作流程整合挑战
资源有限的国家采用缓慢
机会
数位病理学中的人工智慧
技术进步
任务
病理学家的短缺和分配不均
资料管理
数位病理学的最新趋势
合作开发更好的解决方案
创新推动市场成长
透过云端运算加强医疗保健服务
数字和计算病理学

第四章监管情况

法规环境
美国
欧洲

第五章市场区隔分析

细分市场
概述
市场分析：按系统
数位IVD设备
数位病理设备
数位病理分析
数位病理通讯平台
数位病理储存平台
远端病理学系统
按类型进行市场分析
数位血液学和临床病理学
数位解剖病理学
数位微生物
数位遗传病理学
数位免疫病理学
数位化学病理学
数位法医学病理学
市场分析：按应用
疾病诊断
药物研发
研发及其他
最终用户的市场分析
医院和诊断中心
生物技术和製药公司
学术中心等
地理分布
市场分析：按地区
北美洲
欧洲
亚太地区
其他地区

第六章新兴趋势与技术

概述
多路復用技术的进展
分子病理学进展
高光谱遥测和频谱成像
空间生物标记整合
整个幻灯片的数位影像
云端运算与数位病理学
数位病理学中的人工智慧
2024年数位病理学的人工智慧进展

第七章 ESG趋势

ESG：简介
主要製造商在数位病理学市场的 ESG永续性
ESG风险评估
BCC 的观点

第八章专利分析

第九章竞争态势

併购/合作
企业市场占有率分析
其他关键策略

第十章附录

调查方法
来源
简称
公司简介
3DHISTECH LTD.
APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.
CORISTA
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS LLC.
KONINKLIJKE PHILIPS NV
LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
VISIOPHARM A/S
XIFIN INC.

简介目录图表

Product Code: HLC161E

The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.

The North American digital pathology market is expected to grow from $3.3 billion in 2024 and is projected to reach $6.0 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

The European digital pathology market is expected to grow from $2.2 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 10.2% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the digital pathology market, providing forecasted trends and sales projections for this market through 2029. It covers key market players, product segments, supporting technologies, emerging trends, competitive intelligence, major geographies and their competitive landscapes, and it offers regional insights. The report's in-depth analysis of market dynamics and their impact(s) forms the foundation for its qualitative assessments and market estimates.

Digital pathology is the process of converting glass slide samples into digital images to enable electronic analysis, storage and sharing. This conversion, which enhances diagnostic accuracy, collaboration and efficiency by facilitating advanced imaging, computational analysis and telepathology, has revolutionized pathology with data-driven insights and remote consultations.

While this report outlines the conventional processes of pathology laboratories, it does not include market analysis for traditional lab devices such as microscopes and slides. The connectivity and network issues discussed are specific to data and information related to pathology lab diagnoses, excluding broader hospital-based mHealth (Mobile Health) concerns. This report's coverage of telepathology is focused on diagnostic applications, research and development (R&D), and education and training but does not address telemedicine at a broader level.

This report addresses regulatory aspects, including innovations; technological advances (patents and approvals); and the latest trends, preferences and developments in digital pathology. As part of its analysis, it segments the digital pathology market by system, type, application and end user. The market has also been segmented into the following major geographies, North America, Asia-Pacific, Europe and the Rest of the World, and there is focused coverage of countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Includes

91 data tables and 57 additional tables
An analysis of the global market for digital pathology technologies
Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Descriptions of the upcoming market opportunities for the digital pathology market, factors driving its growth, and forecasts for this market's segments and sub-segments
Estimates of the market size and forecasts for the digital pathology market in value (USD millions) terms, and a corresponding market share analysis by system, type, application, end user and geographic region
In-depth information regarding major market dynamics, technology updates, new products and applications, and COVID-19's impact on the market for digital pathology
Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2029
Information on mergers and acquisitions, agreements, collaborations and product launches in the digital pathology industry
Analysis of relevant patents
A discussion of the industry's ESG challenges and practices
Analysis of the competitive landscape for digital pathology companies, and a value share analysis based on their segmental revenues and financial performance
Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Nikon Instruments Inc., Danaher Corp., and Indica Labs Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Market Overview
Historical Development of Digital Pathology
Conventional Process Versus Digital Pathology

Chapter 3 Market Dynamics

Overview
Drivers
Cost-Effectiveness Drives Digital Pathology Expansion
Growing Adoption of Digital Pathology to Enhance Lab Efficiency
Increasing Incidence of Cancer
Increasing Investments and Funding in Digital Pathology
Restraints
Workflow Integration
Slow Implementation of Digital Pathology in Low-Resource Countries
Opportunities
AI in Digital Pathology
Technology Advances
Challenges
Shortage and Unequal Distribution of Pathologists
Data Management
Current Trends in Digital Pathology
Collaborations to Develop Better Solutions
Innovations to Drive Market Growth
Cloud Computing to Enhance Healthcare Delivery Systems
Digital and Computational Pathology

Chapter 4 Regulatory Landscape

Regulatory Environment
U.S.
Europe

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Overview
Market Analysis by System
Digital IVD devices
Digital Pathology Devices
Digital Pathology Analytics
Digital Pathology Communication Platform
Digital Pathology Storage Platform
Telepathology Systems
Market Analysis by Type
Digital Hematology and Clinical Pathology
Digital Anatomical Pathology
Digital Microbiology
Digital Genetic Pathology
Digital Immunopathology
Digital Chemical Pathology
Digital Forensic Pathology
Market Analysis by Application
Disease Diagnosis
Drug Discovery and Development
R&D and Others
Market Analysis by End User
Hospitals and Diagnostic Centers
Biotech and Pharma Companies
Academic Centers and Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World

Chapter 6 Emerging Trends and Technologies

Overview
Advances in Multiplexing Methods
Advancing Molecular Pathology
Hyperspectral and Multispectral Imaging
Spatial Biomarker Integration
Whole Slide Digital Imaging
Cloud Computing and Digital Pathology
AI in Digital Pathology
Advances in AI in Digital Pathology in 2024

Chapter 7 ESG Developments

Introduction to ESG
ESG Sustainability in Digital Pathology Market, by Major Manufacturers
ESG Risk Ratings
BCC Research Viewpoint

Chapter 8 Patent Analysis

Overview
Digital Pathology

Chapter 9 Competitive Landscape

Mergers, Acquisitions and Collaborations
Company Share Analysis
Other Key Strategies

Chapter 10 Appendix

Methodology
Sources
Abbreviations
Company Profiles
3DHISTECH LTD.
APOLLO ENTERPRISE IMAGING CORP.
CLINISYS INC.
CORISTA
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS LLC.
KONINKLIJKE PHILIPS N.V.
LEICA BIOSYSTEMS NUSSLOCH GMBH
LIGOLAB INFORMATION SYSTEMS
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
VISIOPHARM A/S
XIFIN INC.
Emerging Start-ups/Market Disrupters

简介目录图表

List of Tables

Summary Table : Global Digital Pathology Market, by Region, Through 2029
Table 1 : Evolution of Pathology: Key Milestones and Technological Advances
Table 2 : Comparison of Traditional Pathology vs. Digital Pathology
Table 3 : Recent Funding for Digital Pathology, 2025
Table 4 : Global Digital Pathology Market, by System, Through 2029
Table 5 : Global Digital Pathology Market, by System, Through 2029
Table 6 : Global Digital IVD Devices Market, by Product, Through 2029
Table 7 : Global Automated Hematology Analyzers and Blood Cell Counters Market, by Region, Through 2029
Table 8 : Global Digital Holographic Microscopy Market, by Region, Through 2029
Table 9 : Global Digital Urine Sediment Analyzers Market, by Region, Through 2029
Table 10 : Global Digital Chromosome Analyzers Market, by Region, Through 2029
Table 11 : Global Immunohistochemistry Image Analysis Applications Market, by Region, Through 2029
Table 12 : Global Digital Polymerase Chain Reaction Market, by Region, Through 2029
Table 13 : Global Digital Cytopathology Market, by Region, Through 2029
Table 14 : Global Digital Cytopathology Market, by Region, Through 2029
Table 15 : Global Signet Cell Detection Market, by Region, Through 2029
Table 16 : Global Digital Pathology Devices Market, by Region, Through 2029
Table 17 : Global Digital Pathology Devices Market, by Type, Through 2029
Table 18 : Global Scanners Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 19 : Global Robotic Microscopes Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 20 : Global Digital Cameras Segment in the Digital Pathology Devices Market, by Region, Through 2029
Table 21 : Global Digital Pathology Analytics Market, by Region, Through 2029
Table 22 : Global Digital Pathology Communication Platform Market, by Region, Through 2029
Table 23 : Global Digital Pathology Storage Platform Market, by Region, Through 2029
Table 24 : Global Telepathology Systems Market, by Region, Through 2029
Table 25 : Global Digital Pathology Market, by Type, Through 2029
Table 26 : Global Digital Hematology and Clinical Pathology Market, by Region, Through 2029
Table 27 : Global Digital Anatomic Pathology Market, by Region, Through 2029
Table 28 : Global Digital Microbiology Market, by Region, Through 2029
Table 29 : Global Digital Genetic Pathology Market, by Region, Through 2029
Table 30 : Global Digital Immunopathology Market, by Region, Through 2029
Table 31 : Global Digital Chemical Pathology Market, by Region, Through 2029
Table 32 : Global Digital Forensic Pathology Market, by Region, Through 2029
Table 33 : Global Digital Pathology Market, by Application, Through 2029
Table 34 : Global Digital Pathology Disease Diagnosis Market, by Region, Through 2029
Table 35 : Global Digital Pathology Drug Discovery and Development Market, by Region, Through 2029
Table 36 : R&D Expenditures in the Global Pharmaceutical Industry, by Leading 19 Companies, 2023
Table 37 : Global Digital Pathology R&D and Others Market, by Region, Through 2029
Table 38 : Global Digital Pathology Market, by End User, Through 2029
Table 39 : Global Digital Pathology Market in Hospitals and Diagnostic Centers, by Region, Through 2029
Table 40 : Global Digital Pathology Market in Biotech and Pharmaceutical Companies, by Region, Through 2029
Table 41 : Global Digital Pathology Market in Academic Centers and Other End-Users, by Region, Through 2029
Table 42 : Global Digital Pathology Market, by Region, Through 2029
Table 43 : North American Digital Pathology Market, by Country, Through 2029
Table 44 : North American Digital Pathology Market, by System, Through 2029
Table 45 : North American Digital Pathology Market, by Type, Through 2029
Table 46 : North American Digital Pathology Market, by Application, Through 2029
Table 47 : North American Digital Pathology Market, by End User, Through 2029
Table 48 : U.S. Digital Pathology Market, by System, Through 2029
Table 49 : U.S. Digital Pathology Market, by Type, Through 2029
Table 50 : Canadian Digital Pathology Market, by System, Through 2029
Table 51 : Canadian Digital Pathology Market, by Type, Through 2029
Table 52 : Mexican Digital Pathology Market, by System, Through 2029
Table 53 : Mexican Digital Pathology Market, by Type, Through 2029
Table 54 : European Digital Pathology Market, by Country, Through 2029
Table 55 : European Digital Pathology Market, by System, Through 2029
Table 56 : European Digital Pathology Market, by Type, Through 2029
Table 57 : European Digital Pathology Market, by Application, Through 2029
Table 58 : European Digital Pathology Market, by End User, Through 2029
Table 59 : U.K. Digital Pathology Market, by System, Through 2029
Table 60 : U.K. Digital Pathology Market, by Type, Through 2029
Table 61 : French Digital Pathology Market, by System, Through 2029
Table 62 : French Digital Pathology Market, by Type, Through 2029
Table 63 : Italian Digital Pathology Market, by System, Through 2029
Table 64 : Italian Digital Pathology Market, by Type, Through 2029
Table 65 : German Digital Pathology Market, by System, Through 2029
Table 66 : German Digital Pathology Market, by Type, Through 2029
Table 67 : Spanish Digital Pathology Market, by System, Through 2029
Table 68 : Spanish Digital Pathology Market, by Type, Through 2029
Table 69 : Rest of the European Digital Pathology Market, by System, Through 2029
Table 70 : Rest of the European Digital Pathology Market, by Type, Through 2029
Table 71 : Asia-Pacific Digital Pathology Market, by Country, Through 2029
Table 72 : Asia-Pacific Digital Pathology Market, by System, Through 2029
Table 73 : Asia-Pacific Digital Pathology Market, by Type, Through 2029
Table 74 : Asia-Pacific Digital Pathology Market, by Application, Through 2029
Table 75 : Asia-Pacific Digital Pathology Market, by End User, Through 2029
Table 76 : Chinese Digital Pathology Market, by System, Through 2029
Table 77 : Chinese Digital Pathology Market, by Type, Through 2029
Table 78 : Indian Digital Pathology Market, by System, Through 2029
Table 79 : Indian Digital Pathology Market, by Type, Through 2029
Table 80 : Japanese Digital Pathology Market, by System, Through 2029
Table 81 : Japanese Digital Pathology Market, by Type, Through 2029
Table 82 : Australian Digital Pathology Market, by System, Through 2029
Table 83 : Australian Digital Pathology Market, by Type, Through 2029
Table 84 : South Korean Digital Pathology Market, by System, Through 2029
Table 85 : South Korean Digital Pathology Market, by Type, Through 2029
Table 86 : Rest of Asia-Pacific Digital Pathology Market, by System, Through 2029
Table 87 : Rest of Asia-Pacific Digital Pathology Market, by Type, Through 2029
Table 88 : Rest of the World Digital Pathology Market, by System, Through 2029
Table 89 : Rest of the World Digital Pathology Market, by Type, Through 2029
Table 90 : Rest of the World Digital Pathology Market, by Application, Through 2029
Table 91 : Rest of the World Digital Pathology Market, by End User, Through 2029
Table 92 : Key Focus Areas in Environmental Sustainability
Table 93 : ESG Highlights, by Major Players, 2023
Table 94 : ESG Risk Rankings for Digital Pathology Solutions Manufacturing Companies, 2023
Table 95 : Mergers and Acquisitions in Digital Pathology Market, 2021-2024
Table 96 : New Product Launches in the Digital Pathology Market, 2021-2024
Table 97 : Other Key Strategies in the Digital Pathology Market, 2022-2025
Table 98 : Information Sources in this Report
Table 99 : Major Abbreviations Used in This Report
Table 100 : 3DHISTECH Ltd.: Company Snapshot
Table 101 : 3DHISTECH Ltd.: Product Portfolio
Table 102 : 3DHISTECH Ltd.: Recent Developments, 2021-2024
Table 103 : Apollo Enterprise Imaging Corp.: Company Snapshot
Table 104 : Apollo Enterprise Imaging Corp.: Product Portfolio
Table 105 : Apollo Enterprise Imaging Corp.: Recent Developments, 2022-2024
Table 106 : Clinisys Inc.: Company Snapshot
Table 107 : CliniSys Inc.: Product Portfolio
Table 108 : CliniSys Inc.: Recent Developments, 2021-2024
Table 109 : Corista: Company Snapshot
Table 110 : Corista: Product Portfolio
Table 111 : Corista: Recent Developments, 2022-2024
Table 112 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 113 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 114 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 115 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021-2024
Table 116 : Fujifilm Holdings Corp.: Company Snapshot
Table 117 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 118 : Fujifilm Holdings Corp.: Product Portfolio
Table 119 : Fujifilm Holdings Corp.: News/Key Developments, 2021-2024
Table 120 : Huron Technologies International Inc.: Company Snapshot
Table 121 : Huron Technologies International Inc.: Product Portfolio
Table 122 : Huron Technologies International Inc.: Recent Developments, 2021-2023
Table 123 : Indica Labs LLC.: Company Snapshot
Table 124 : Indica Labs LLC.: Product Portfolio
Table 125 : Indica Labs LLC.: Recent Developments, 2022-2025
Table 126 : Koninklijke Philips N.V.: Company Snapshot
Table 127 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 128 : Koninklijke Philips N.V.: Product Portfolio
Table 129 : Koninklijke Philips N.V.: News/Key Developments, 2021-2024
Table 130 : Leica Biosystems Nussloch GmbH.: Company Snapshot
Table 131 : Leica Biosystems Nussloch GmbH: Product Portfolio
Table 132 : Leica Biosystems Nussloch GmbH: Recent Developments, 2021-2025
Table 133 : LigoLab Information Systems: Company Snapshot
Table 134 : LigoLab Information Systems: Product Portfolio
Table 135 : Mikroscan Technologies Inc.: Company Snapshot
Table 136 : Mikroscan Technologies Inc.: Product Portfolio
Table 137 : Mikroscan Technologies Inc.: Recent Developments, 2021 and 2024
Table 138 : Nikon Instruments Inc.: Company Snapshot
Table 139 : Nikon Instruments Inc.: Product Portfolio
Table 140 : Nikon Instruments Inc.: Recent Developments, 2021-2024
Table 141 : Visiopharm A/S: Company Snapshot
Table 142 : Visiopharm A/S: Product Portfolio
Table 143 : Visiopharm A/S: Recent Developments, 2021-2024
Table 144 : XIFIN Inc.: Company Snapshot
Table 145 : XIFIN Inc.: Product Portfolio
Table 146 : XIFIN Inc.: Recent Developments, 2021-2022
Table 147 : List of Few Emerging Startups

List of Figures

Summary Figure : Global Digital Pathology Market Shares, by Region, 2023
Figure 1 : Digital Pathology Adopters, 2025
Figure 2 : Snapshot of Market Dynamics
Figure 3 : Global Shares of Cancer Incidence (New) Cases, by WHO Region, 2022
Figure 4 : Global Shares of Cancer Mortality Cases, by WHO Region, 2022
Figure 5 : U.S. Digital Health Funding and Number of Deals, 2012-2022
Figure 6 : Distribution of Pathologists, by Continent, 2019-2022
Figure 7 : Global Digital Pathology Market Shares, by System, 2023
Figure 8 : Global Digital Pathology Market Shares, by Type, 2023
Figure 9 : Global Digital Pathology Market Shares, by Application, 2023
Figure 10 : Global Digital Pathology Market Shares, by End User, 2023
Figure 11 : Global Digital Pathology Market Shares, by Region, 2023
Figure 12 : 2024 Progress Assessment: Tracking the Sustainable Development Goals
Figure 13 : Patents Documented, by Top Owners, 2021-2024
Figure 14 : Share of Patents Documented, by Jurisdiction, 2021-2024
Figure 15 : Patents Documented Over Time, 2010-November 2024
Figure 16 : Shares of Global Market for Medical Imaging, by Leading Manufacturers, 2023
Figure 17 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 18 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 19 : Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 22 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023

02-2729-4219

+886-2-2729-4219

License/价格

数位病理学：技术与全球市场

Digital Pathology: Technologies and Global Markets